Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Cytokines

Recombinant Human IL31 Protein, N-His

Catalog #:   YHJ05001 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q6EBC2
Protein length: Ser24-Thr164
Overview

Catalog No.

YHJ05001

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Ser24-Thr164

Predicted molecular weight

18.14 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q6EBC2

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

IL-31, Interleukin-31, IL31

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human IL31 protein
References

Antipruritic Effect of 2,3-Dehydrosilybin in Glial Cells and Chloroquine-Treated Mice., PMID:40443235

Use of Nemolizumab in the Treatment of Prurigo Nodularis and Atopic Dermatitis., PMID:40403168

Nemolizumab Improves Pruritus in Patients With Intrinsic Atopic Dermatitis Lacking Atopic Predisposition: A Single-Centre Pilot Retrospective Cohort Study., PMID:40372094

Tartaric Acid Exacerbates DSS-Induced Colitis by Promoting Eosinophilic Inflammation via IL-13 and IL-5Rα Upregulation., PMID:40333150

Serum Concentrations of IL-18, IL-21, IL-22, IL-23, IL-27, and IL-31 in Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and Their Correlation With Disease Severity., PMID:40322299

The Role of Eosinophils, Eosinophil-Related Cytokines and AI in Predicting Immunotherapy Efficacy in NSCLC., PMID:40305195

New and Emerging Biologics and Jak Inhibitors for the Treatment of Prurigo Nodularis: A Narrative Review., PMID:40282922

Evaluation of pruritus biomarkers expression in chronic spontaneous urticaria., PMID:40261414

Osthole ameliorates chronic pruritus in 2,4-dichloronitrobenzene-induced atopic dermatitis by inhibiting IL-31 production., PMID:40256714

Topical Application of Fluoxetine Improves DNCB-Induced Atopic Dermatitis in Mice., PMID:40243303

Effectiveness and Safety of Nemolizumab in Patients with Prurigo Nodularis: a Systematic Review and Meta-Analysis of Randomized Controlled Trials., PMID:40205064

Phenotype-endotype relationship in elderly atopic dermatitis and effects of dupilumab therapy: prospective study., PMID:40095170

Effect of the Combination of Hemodialysis and., PMID:40056446

Clinical Investigation of IL-31, TOS and GSH in the Sera of Gastric Cancer Females Patients In Iraq., PMID:40022705

Assessing the Causal Relationship Between Plasma Proteins and Pulmonary Fibrosis: A Systematic Analysis Based on Mendelian Randomization., PMID:40001968

Elevated Type 2 Inflammatory Factors, Th2/Th1 Balanced Status, and Exosomes as a Marker of Severity in Chronic Actinic Dermatitis., PMID:39949921

WISIT vaccines based on IL-31-derived peptides as a novel therapeutic approach for chronic pruritic dermatoses., PMID:39932924

Pre- and Postnatal Development Study of Nemolizumab, a Humanized Anti-Interleukin-31 Receptor A Monoclonal Antibody, in Cynomolgus Monkey., PMID:39868832

IL-4, TSLP and IL-31 Cytokine Profiles as Related to Psychometric Measures in Patients with Mastocytosis., PMID:39859245

Exploring the Involvement of New Members of the Interleukin Family in Cardiovascular Disease., PMID:39844544

Reconstructed Epidermis Produced with Atopic Dog Keratinocytes Only Exhibit Skin Barrier Defects after the Addition of Proinflammatory and Allergic Cytokines., PMID:39811760

Type 2 cytokine-JAK1 signaling is involved in the development of dry skin-induced mechanical alloknesis., PMID:39616021

Predictive cytokines of omalizumab in the treatment of chronic spontaneous urticaria., PMID:39602877

Interleukin 31 mediates pruritus in horses., PMID:39406262

Comparative effectiveness of upadacitinib versus dupilumab for moderate-to-severe atopic dermatitis: A retrospective cohort study., PMID:39405928

The diagnostic value and validation of IL-22 combimed with sCD40L in tuberculosis pleural effusion., PMID:39385103

Biomarkers of type 2 and non-type 2 inflammation in asthma exacerbations., PMID:39381551

Emerging Biologic Therapies for the Treatment of Atopic Dermatitis., PMID:39365406

Oral Administration of Lactococcus lactis Expressing Mite and Cockroach Major Allergens Alleviates Progression of Atopic March in a Mouse Model., PMID:39363770

Interleukin-31: The Inflammatory Cytokine Connecting Pruritus and Cancer., PMID:39344323

Cytokine profile of the stratum corneum in atopic dermatitis lesions differs between the face and the trunk., PMID:39332980

Interleukin 31 in vitiligo patients with and without pruritus., PMID:39324348

OpzeluraTM (Ruxolitinib) Cream 1.5., PMID:39285571

Cannabinol modulates the endocannabinoid system and shows TRPV1-mediated anti-inflammatory properties in human keratinocytes., PMID:39275884

Pyrazolines inhibiting the activity of the early growth response-1 DNA-binding domain., PMID:39265893

Cord Blood Serum Levels of IL-31 and CCL17, Cutaneous Markers, and Development of Atopic Dermatitis., PMID:39259556

Comparison of serum cytokines and chemokines levels and clinical significance in patients with pemphigus vulgaris-A retrospective study., PMID:39246287

Trichohyalin gene expression is negatively correlated with the severity of dermatitis in a canine atopic dermatitis model., PMID:39234173

Anti-atopic dermatitis effect of fraxinellone via inhibiting IL-31 in vivo and in vitro., PMID:39170490

Long-term use of lokivetmab in dogs with atopic dermatitis., PMID:39143659

Diospyros lotus leaf extract and its main component myricitrin inhibit itch‑related IL‑6 and IL‑31 by suppressing microglial inflammation and microglial‑mediated astrocyte activation., PMID:39129303

Interleukin Profiling in Atopic Dermatitis and Chronic Nodular Prurigo., PMID:39126011

Lasmiditan ameliorates serotonergic itch in mice: Possible involvement of 5-HT1F receptors., PMID:39115558

Cytokines and chemokines skin gene expression in correlation with immune cells in blood and severity in equine insect bite hypersensitivity., PMID:39076967

Characterization of cells and mediators associated with pruritus in primary cutaneous T-cell lymphomas., PMID:39068637

Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials., PMID:39067461

Celastrol alleviates atopic dermatitis by regulating Ezrin-mediated mitochondrial fission and fusion., PMID:39039796

Clinical characteristics, immunological alteration and distinction of MOG-IgG-associated disorders and GFAP-IgG-associated disorders., PMID:39002186

Inflammatory profile of patients with different weight diagnoses and similar periodontal condition: A systematic review., PMID:38988953

Altered expression of cytokines, chemokines, growth factors, and soluble receptors in patients with colorectal cancer, and correlation with treatment outcome., PMID:38954024

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human IL31 Protein, N-His [YHJ05001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only